Ad is loading...
DSGN
Price
$5.80
Change
-$0.22 (-3.65%)
Updated
Nov 15 closing price
108 days until earnings call
LENZ
Price
$33.20
Change
-$0.73 (-2.15%)
Updated
Nov 15 closing price
Ad is loading...

DSGN vs LENZ

Header iconDSGN vs LENZ Comparison
Open Charts DSGN vs LENZBanner chart's image
Design Therapeutics
Price$5.80
Change-$0.22 (-3.65%)
Volume$240.52K
CapitalizationN/A
LENZ Therapeutics
Price$33.20
Change-$0.73 (-2.15%)
Volume$172.34K
CapitalizationN/A
DSGN vs LENZ Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DSGN vs. LENZ commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Sell and LENZ is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (DSGN: $5.80 vs. LENZ: $33.20)
Brand notoriety: DSGN and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 125% vs. LENZ: 94%
Market capitalization -- DSGN: $328.4M vs. LENZ: $913.03M
DSGN [@Biotechnology] is valued at $328.4M. LENZ’s [@Biotechnology] market capitalization is $913.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, LENZ is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 6 TA indicator(s) are bullish while LENZ’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 6 bullish, 4 bearish.
  • LENZ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than LENZ.

Price Growth

DSGN (@Biotechnology) experienced а -0.51% price change this week, while LENZ (@Biotechnology) price change was -5.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.92%. For the same industry, the average monthly price growth was -6.94%, and the average quarterly price growth was -0.62%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 06, 2025.

LENZ is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-8.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($913M) has a higher market cap than DSGN($328M). LENZ YTD gains are higher at: 1167.176 vs. DSGN (118.868). DSGN has more cash in the bank: 261M vs. LENZ (196M). LENZ has less debt than DSGN: LENZ (1.7M) vs DSGN (2.7M).
DSGNLENZDSGN / LENZ
Capitalization328M913M36%
EBITDA-62.82MN/A-
Gain YTD118.8681167.17610%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash261M196M133%
Total Debt2.7M1.7M159%
TECHNICAL ANALYSIS
Technical Analysis
DSGNLENZ
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Ad is loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFVZX19.40-0.10
-0.51%
MassMutual Equity Opports I
ARRBX15.07-0.15
-0.99%
Aristotle Small Cap Eq R6
JAGIX78.58-0.95
-1.19%
Janus Henderson Growth And Income T
EMCAX66.65-1.19
-1.75%
Empiric Class A
GGEYX30.05-0.63
-2.05%
GuideStone Funds Growth Equity Instl

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with CYTK. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-3.65%
CYTK - DSGN
39%
Loosely correlated
-8.19%
MDGL - DSGN
38%
Loosely correlated
-4.66%
AGIO - DSGN
36%
Loosely correlated
-2.92%
RCKT - DSGN
36%
Loosely correlated
-5.67%
TERN - DSGN
34%
Loosely correlated
-5.80%
More

LENZ and

Correlation & Price change

A.I.dvisor tells us that LENZ and OTLK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LENZ and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-2.15%
OTLK - LENZ
32%
Poorly correlated
-1.81%
IVVD - LENZ
31%
Poorly correlated
-4.48%
DSGN - LENZ
25%
Poorly correlated
-3.65%
OCGN - LENZ
24%
Poorly correlated
-6.14%
TCRX - LENZ
24%
Poorly correlated
-8.51%
More